Metastatic melanoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Melanocytes Lymphocytes, Tumor-Infiltrating Cell Line, Tumor Tumor Cells, Cultured T-Lymphocytes, Cytotoxic Lymph Nodes Neoplastic Cells, Circulating CD8-Positive T-Lymphocytes T-Lymphocytes Clone Cells Skin Dendritic Cells Killer Cells, Natural Cell Line Chromosomes, Human, Pair 10 Chromosomes, Human, Pair 6 Cytokine-Induced Killer Cells Cells, Cultured Killer Cells, Lymphokine-Activated Lymphocytes Neoplastic Stem Cells Lymphocyte Subsets CD4-Positive T-Lymphocytes

Organisms6

Mice, Nude Mice, Inbred C57BL Canarypox virus Mice, SCID Cyprinodontiformes Mice, Inbred BALB C

Diseases38

Melanoma Skin Neoplasms Melanoma, Experimental Neoplasm Metastasis Nevus Nevus, Pigmented Melanoma, Amelanotic Uveal Neoplasms Choroid Neoplasms Dysplastic Nevus Syndrome Disease Progression Lymphatic Metastasis Eye Neoplasms Neoplasm Invasiveness Vitiligo Brain Neoplasms Lung Neoplasms Neoplastic Cells, Circulating Sarcoma, Clear Cell Chills Neoplasms Neovascularization, Pathologic Hemospermia Neoplasm Recurrence, Local Iris Neoplasms Hutchinson's Melanotic Freckle Abdominal Neoplasms Liver Neoplasms Melanosis Carcinoma, Renal Cell Kidney Neoplasms Hypersensitivity, Delayed Thrombocytopenia Nevus, Epithelioid and Spindle Cell Conjunctival Neoplasms Fatigue Sunburn Cell Transformation, Neoplastic

Chemicals and Drugs79

MART-1 Antigen Dacarbazine gp100 Melanoma Antigen Proto-Oncogene Proteins B-raf Antigens, Neoplasm Melanoma-Specific Antigens Cancer Vaccines Monophenol Monooxygenase Interleukin-2 Neoplasm Proteins Antineoplastic Agents Interferon-alpha Melanins Antibodies, Monoclonal Microphthalmia-Associated Transcription Factor CTLA-4 Antigen HLA-A2 Antigen Tumor Markers, Biological Antineoplastic Agents, Alkylating Sulfonamides Cysteinyldopa Oximes alpha-MSH Antigens, CD146 Recombinant Proteins Cisplatin S100 Proteins Indoles Antigens, CD Gangliosides Vinblastine Antibodies, Neoplasm RNA, Messenger Membrane Glycoproteins Granulocyte-Macrophage Colony-Stimulating Factor DNA, Neoplasm HLA-A Antigens Proto-Oncogene Proteins c-kit Indium Radioisotopes RNA, Small Interfering Protein Kinase Inhibitors Carmustine Immunologic Factors Lomustine Benzenesulfonates Niacinamide Receptor, Melanocortin, Type 1 Vaccines, Subunit Intramolecular Oxidoreductases RNA, Neoplasm Phenylurea Compounds Interferon-gamma Benzamides Peptides L-Lactate Dehydrogenase Hemocyanin Interleukins Epitopes, T-Lymphocyte Nestin PTEN Phosphohydrolase Antigens, Differentiation Imidazoles Peptide Fragments Antibodies, Blocking Proto-Oncogene Proteins c-bcl-2 Antineoplastic Agents, Phytogenic Inhibitor of Apoptosis Proteins Receptors, Antigen, T-Cell Membrane Proteins Immunoconjugates HLA Antigens Adjuvants, Immunologic Cytokines Radiopharmaceuticals Tamoxifen Pyrimidines Paclitaxel Tumor Suppressor Proteins Angiogenesis Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Melanoma, Experimental Immunotherapy Immunotherapy, Adoptive Treatment Outcome Immunohistochemistry Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Survival Analysis Injections, Intralesional Neoplasm Transplantation Prognosis Survival Rate Disease-Free Survival Sentinel Lymph Node Biopsy Drug Administration Schedule Immunotherapy, Active Eye Enucleation Reverse Transcriptase Polymerase Chain Reaction Injections, Subcutaneous Combined Modality Therapy Flow Cytometry Monitoring, Immunologic Drug Screening Assays, Antitumor Transplantation, Heterologous Injections, Intralymphatic Drug Evaluation Clinical Trials, Phase II as Topic Kaplan-Meier Estimate Xenograft Model Antitumor Assays Molecular Targeted Therapy Lymph Node Excision Tumor Burden Dermoscopy Blotting, Western Fatal Outcome Remission Induction Pigmentation Maximum Tolerated Dose Gene Expression Profiling Tissue Array Analysis Immunoenzyme Techniques Clinical Trials as Topic Infusions, Intravenous Retrospective Studies Transfection Oligonucleotide Array Sequence Analysis Biopsy Genetic Therapy Sensitivity and Specificity Skin Pigmentation DNA Mutational Analysis Polymerase Chain Reaction Lymphocyte Activation Adoptive Transfer Tomography, X-Ray Computed Enzyme-Linked Immunosorbent Assay Paraffin Embedding Biopsy, Fine-Needle Vaccination Pilot Projects False Negative Reactions Follow-Up Studies Proportional Hazards Models Gene Knockdown Techniques Lymphocyte Count Primary Cell Culture Prospective Studies Clinical Trials, Phase III as Topic Gene Transfer Techniques

Phenomena and Processes41

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Cell Movement Mutation Signal Transduction Cytotoxicity, Immunologic Drug Resistance, Neoplasm Time Factors Cell Division Down-Regulation Cell Survival Cell Adhesion Dose-Response Relationship, Drug Pigmentation Maximum Tolerated Dose Sunlight Phenotype Transfection Drug Synergism Base Sequence Up-Regulation Sensitivity and Specificity Skin Pigmentation Chromosomes, Human, Pair 10 Genes, ras Chromosomes, Human, Pair 6 Lymphocyte Activation Gene Expression Cell Cycle Tumor Microenvironment RNA Interference Genes, Tumor Suppressor Amino Acid Sequence Hair Color MAP Kinase Signaling System Tissue Distribution Lymphocyte Count Loss of Heterozygosity Autoimmunity Promoter Regions, Genetic

Disciplines and Occupations1

Immunohistochemistry

Information Science5

Survival Rate Fatal Outcome Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care17

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival Clinical Trials, Phase II as Topic Kaplan-Meier Estimate Fatal Outcome Clinical Trials as Topic Sunlight Retrospective Studies Sensitivity and Specificity Vaccination Pilot Projects Follow-Up Studies Proportional Hazards Models Prospective Studies Clinical Trials, Phase III as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Melanoma Skin Neoplasms Melanoma, Experimental Neoplasm Metastasis MART-1 Antigen Dacarbazine gp100 Melanoma Antigen Nevus Nevus, Pigmented Proto-Oncogene Proteins B-raf Melanoma, Amelanotic Uveal Neoplasms Antigens, Neoplasm Melanoma-Specific Antigens Melanocytes Lymphocytes, Tumor-Infiltrating Cell Line, Tumor Cancer Vaccines Choroid Neoplasms Dysplastic Nevus Syndrome Monophenol Monooxygenase Interleukin-2 Neoplasm Proteins Immunotherapy Antineoplastic Agents Tumor Cells, Cultured Immunotherapy, Adoptive Treatment Outcome Gene Expression Regulation, Neoplastic Interferon-alpha Melanins Antibodies, Monoclonal Microphthalmia-Associated Transcription Factor Disease Progression Lymphatic Metastasis CTLA-4 Antigen Immunohistochemistry Eye Neoplasms Neoplasm Invasiveness HLA-A2 Antigen Tumor Markers, Biological Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Alkylating Survival Analysis Sulfonamides Cysteinyldopa Injections, Intralesional Neoplasm Transplantation Mice, Nude Prognosis Vitiligo Oximes alpha-MSH Antigens, CD146 Recombinant Proteins Brain Neoplasms Survival Rate Cell Proliferation Disease-Free Survival Cisplatin Sentinel Lymph Node Biopsy Apoptosis Lung Neoplasms S100 Proteins Drug Administration Schedule Indoles Immunotherapy, Active Eye Enucleation Antigens, CD Reverse Transcriptase Polymerase Chain Reaction Injections, Subcutaneous Cell Movement Mutation T-Lymphocytes, Cytotoxic Combined Modality Therapy Gangliosides Flow Cytometry Mice, Inbred C57BL Vinblastine Lymph Nodes Monitoring, Immunologic Antibodies, Neoplasm RNA, Messenger Neoplastic Cells, Circulating CD8-Positive T-Lymphocytes Membrane Glycoproteins T-Lymphocytes Granulocyte-Macrophage Colony-Stimulating Factor Drug Screening Assays, Antitumor Signal Transduction Transplantation, Heterologous Cytotoxicity, Immunologic Clone Cells Injections, Intralymphatic Drug Resistance, Neoplasm DNA, Neoplasm Drug Evaluation Time Factors HLA-A Antigens

No FAQ available that match "metastatic melanoma"